Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Acasti Pharma Inc ACST

Acasti Pharma Inc. is a Canada-based late-stage biopharma company with drug candidates addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: GTX-104, an intravenous infusion targeting subarachnoid hemorrhage (SAH), a rare and life-threatening medical emergency, in which bleeding occurs over the surface of the brain in the subarachnoid space between the... see more

NDAQ:ACST - Post Discussion

Acasti Pharma Inc > Alex seems pumped on ACST
View:
Post by Canadian_101 on Dec 02, 2019 11:58am

Alex seems pumped on ACST

https://www.bnnbloomberg.ca/video/alex-ruus-discusses-acasti-pharma~1842886
Comment by panda55 on Dec 02, 2019 3:04pm
 please excuse my inposition but the BNN ACST piece wont play on my computer.. may  i trouble you to provide a short summation please. thanks
Comment by panda55 on Dec 02, 2019 3:08pm
 got it to play.  thanks anyway.
Comment by candele on Dec 03, 2019 12:39am
This post has been removed in accordance with Community Policy
Comment by hipfner on Dec 03, 2019 8:56am
I've held this for years. Frankly I had no appreciation of how long a process it was to go from idea to Phase 3. Now that is nearly over and I also anticipate (yet another) successful trial. Then another set of results in early 2020. Then eventual govt. approval.  I am hoping that a bidding war starts soon as Acasti is totally unprepared to commercialize the drug and market it. There ...more  
Comment by Mcburnz on Dec 03, 2019 5:26pm
Only thing I can see derailing this is they underestimated the dosage needed to get the reduction in the high level patients....we will c next week 20 % I see being attainable.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities